- Home
- SONO vs RXRX Comparison
SONO vs RXRX Comparison
Compare SONO & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SONO | RXRX |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SONO | RXRX |
|---|---|---|
| Price | $13.76 | $3.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $19.67 | $7.50 |
| AVG Volume (30 Days) | 1.7M | ★ 19.9M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $1,443,276,000.00 | $74,681,000.00 |
| Revenue This Year | $5.04 | $12.11 |
| Revenue Next Year | $6.53 | $82.52 |
| P/E Ratio | $27.06 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $10.12 | $2.77 |
| 52 Week High | $19.82 | $7.18 |
Technical Indicators
Market Signals| Indicator | SONO | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.54 | 53.11 |
| Support Level | $12.67 | $2.88 |
| Resistance Level | $14.76 | $4.01 |
| Average True Range (ATR) | 0.77 | 0.23 |
| MACD | -0.19 | 0.00 |
| Stochastic Oscillator | 5.86 | 54.00 |
Price Performance
Historical ComparisonAbout SONO Sonos Inc.
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.